CD4 cell and CD8 cell-mediated resistance to HIV-1 infection in exposed uninfected intravascular drug users in Vietnam. (Q53925928)

22 May 2018

title

CD4 cell and CD8 cell-mediated resistance to HIV-1 infection in exposed uninfected intravascular drug users in Vietnam. (English)

1 reference

22 May 2018

main subject

Vietnam

0 references

author

Françoise Barré-Sinoussi

13

object named as

Françoise Barré-Sinoussi

1 reference

22 May 2018

3

Daniel Scott-Algara

1 reference

22 May 2018

10

Arnaud Fontanet

1 reference

22 May 2018

14

Gianfranco Pancino

1 reference

22 May 2018

Pierre Versmisse

4

object named as

Pierre Versmisse

1 reference

22 May 2018

author name string

Lien X Truong

1

1 reference

22 May 2018

Tram T Luong

2

1 reference

22 May 2018

Annie David

5

1 reference

22 May 2018

Danielle Perez-Bercoff

6

1 reference

22 May 2018

Ngai V Nguyen

7

1 reference

22 May 2018

Hung K Tran

8

1 reference

22 May 2018

Cuc T Cao

9

1 reference

22 May 2018

Jean-Yves Follézou

11

1 reference

22 May 2018

Ioannis Theodorou

12

1 reference

22 May 2018

language of work or name

English

0 references

publication date

1 July 2003

1 reference

22 May 2018

published in

AIDS

1 reference

22 May 2018

volume

17

1 reference

22 May 2018

issue

10

1 reference

22 May 2018

page(s)

1425-1434

1 reference

22 May 2018

Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells

cites work

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1126/SCIENCE.270.5243.1811

Resistance against syncytium-inducing human immunodeficiency virus type 1 (HIV-1) in selected CD4(+) T cells from an HIV-1-infected nonprogressor: evidence of a novel pathway of resistance mediated by a soluble factor(s) that acts after virus entry

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00002030-200307040-00002

No difference in in vitro susceptibility to HIV type 1 between high-risk HIV-negative Ethiopian commercial sex workers and low-risk control subjects.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00002030-200307040-00002

Human immunodeficiency virus type 1 T-lymphotropic strains enter macrophages via a CD4- and CXCR4-mediated pathway: replication is restricted at a postentry level

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00002030-200307040-00002

Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00002030-200307040-00002

Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00002030-200307040-00002

Susceptibility of in vitro stimulated PBMC to infection with NSI HIV-1 is associated with levels of CCR5 expression and beta-chemokine production

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00002030-200307040-00002

Activation of human monocyte--derived macrophages with lipopolysaccharide decreases human immunodeficiency virus replication in vitro at the level of gene expression

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00002030-200307040-00002

CD3+CD8+ cell levels as predictors of transmission in human immunodeficiency virus-infected couples: a report from the heterosexual HIV transmission study

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00002030-200307040-00002

Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00002030-200307040-00002

In vitro correlates of HIV-2-mediated HIV-1 protection

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00002030-200307040-00002

Protective immunity against HIV infection: has nature done the experiment for us?

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00002030-200307040-00002

Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00002030-200307040-00002

Immune responses in HIV-exposed seronegatives: have they repelled the virus?

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00002030-200307040-00002

CCR5 expression correlates with susceptibility of maturing monocytes to human immunodeficiency virus type 1 infection

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00002030-200307040-00002

HIV type 1 resistance in Kenyan sex workers is not associated with altered cellular susceptibility to HIV type 1 infection or enhanced beta-chemokine production

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00002030-200307040-00002

Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00002030-200307040-00002

Contribution of human alpha-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00002030-200307040-00002

Restriction of lentivirus in monkeys

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00002030-200307040-00002

HIV-Specific Cytotoxic T Lymphocytes, HLA-A11, and Chemokine-Related Factors May Act Synergistically to Determine HIV Resistance in CCR5 Δ32-Negative Female Sex Workers in Chiang Rai, Northern Thailand

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00002030-200307040-00002

Diagnosis of HIV-1 group O infection by polymerase chain reaction

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00002030-200307040-00002

Production of a novel viral suppressive activity associated with resistance to infection among female sex workers exposed to HIV type 1

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00002030-200307040-00002

Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00002030-200307040-00002

Human immunodeficiency virus (HIV)-specific IgA and HIV neutralizing activity in the serum of exposed seronegative partners of HIV-seropositive persons

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00002030-200307040-00002

Influence of HLA supertypes on susceptibility and resistance to human immunodeficiency virus type 1 infection

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00002030-200307040-00002

Factors contributing to the lack of human immunodeficiency virus type 1 (HIV-1) transmission in HIV-1-discordant partners.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00002030-200307040-00002

CCR5-reactive antibodies in seronegative partners of HIV-seropositive individuals down-modulate surface CCR5 in vivo and neutralize the infectivity of R5 strains of HIV-1 In vitro.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00002030-200307040-00002

HIV-1-specific mucosal CD8+ lymphocyte responses in the cervix of HIV-1-resistant prostitutes in Nairobi.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00002030-200307040-00002

HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00002030-200307040-00002

HIV type 1 Thai subtype E is predominant in South Vietnam.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00002030-200307040-00002

HIV-specific CD8 T-cell activity in uninfected injection drug users is associated with maintenance of seronegativity

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00002030-200307040-00002

Rhesus macaque resistance to mucosal simian immunodeficiency virus infection is associated with a postentry block in viral replication

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00002030-200307040-00002

Correlates of nontransmission in US women at high risk of human immunodeficiency virus type 1 infection through sexual exposure

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00002030-200307040-00002

Human immunodeficiency virus (HIV)-specific cytotoxic T lymphocyte activity in HIV-exposed seronegative persons

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00002030-200307040-00002

Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00002030-200307040-00002

Selection of maternal human immunodeficiency virus type 1 variants in human placenta. European Network for In Utero Transmission of HIV-1.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00002030-200307040-00002

Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00002030-200307040-00002

Change in coreceptor use correlates with disease progression in HIV-1--infected individuals

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00002030-200307040-00002

Cell surface CCR5 density determines the postentry efficiency of R5 HIV-1 infection

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00002030-200307040-00002

Detection of elevated serum beta-chemokine levels in seronegative Chinese individuals exposed to human immunodeficiency virus type 1.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00002030-200307040-00002

Naturally occurring deletional mutation in the C-terminal cytoplasmic tail of CCR5 affects surface trafficking of CCR5.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00002030-200307040-00002

HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00002030-200307040-00002

Lack of infection in HIV-exposed individuals is associated with a strong CD8(+) cell noncytotoxic anti-HIV response

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00002030-200307040-00002

HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00002030-200307040-00002

Evidence for a post-entry barrier to R5 HIV-1 infection of CD4 memory T cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00002030-200307040-00002

Naïve and memory CD4 T cells differ in their susceptibilities to human immunodeficiency virus type 1 infection following CD28 costimulation: implicatip6s for transmission and pathogenesis.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00002030-200307040-00002

Protection against human immunodeficiency virus type 1 infection in persons with repeated exposure: evidence for T cell immunity in the absence of inherited CCR5 coreceptor defects

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00002030-200307040-00002

Epidemiologic and biologic characterization of a cohort of human immunodeficiency virus type 1 highly exposed, persistently seronegative female sex workers in northern Thailand. Chiang Mai HEPS Working Group

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00002030-200307040-00002

CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00002030-200307040-00002

Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00002030-200307040-00002

Sexual transmission of HIV.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00002030-200307040-00002

Genotypic and phenotypic characterization of HIV-1 patients with primary infection

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00002030-200307040-00002

C-C chemokines, pivotal in protection against HIV type 1 infection

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00002030-200307040-00002

Human immunodeficiency virus type 1 (HIV-1)-seronegative injection drug users at risk for HIV exposure have antibodies to HLA class I antigens and T cells specific for HIV envelope

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00002030-200307040-00002

Identifiers

DOI

10.1097/00002030-200307040-00002

1 reference

22 May 2018

PubMed ID

12824779

1 reference

22 May 2018